Dichloroacetate

DCA

The Little Cancer Cure that Could

DCA or Dichloroacetate Sodium has been used for decades to treat lactic acidosis in humans.  It has been thoroughly studied and experienced to verify that it has little toxicity and is well tolerated for human consumption.  At the University of Alberta in the year 2007, Dr Evengelos Michelakis, medical researcher and associate chair at the university’s faculty of medicine and his team of clinical researchers found an effective cure for cancer.

Years after his work was published in Science Translational Medicine (August 2010), Circulation (2002, 2006), Circulation Research (2004), PNSAS (2007), Journal of Clinical Investigation (JCI), the University of Alberta’s research team still isn’t receiving any support from the medical industry.  This simple compound which costs pennies per dose, would cost the pharmaceutical companies many billions of dollars.  Then there would be tremendous loss in revenue from other cancer treatments such as radiation and surgery.  The reason such a promising cancer treatment has languished is because it cannot be patented.  It is preexisting.  Not only can money not be made from it, it will cost the afore mentioned medical industry billions and billions of dollars.  Big Pharma sees DCA as a formidable competitor.  

In the original research, breast, brain and lung cancer cells from humans were implanted in rats.  It was found that DCA would activate natural cell death in the imbedded cancer cells.  Additionally, it was observed that DCA prevented the mechanism by which glucose is consumed by cancer cells which effectively deprived the cells of their source of energy causing them to starve.  DCA did not have that effect on normal body cells.  Worldwide, researchers have duplicated and confirmed the findings of Dr. Michelakis and his team.

DCA has since been found to be effective for a broad range of cancers and there have been some trials in the stage 1 or 2 category that show very positive results.  To launch stage 3 and 4 studies of large numbers of people requires a large amount of money and a supporting institution such as John’s Hopkins to step forward and host the trials.  As we have seen with other promising orphan treatments such as with Dr. Burzynski (who got his very promising and effective anti-neoplastins up to the final stage 4 trail), it is impossible to find an institution to host the trials because they are pressured by Big Pharma to decline.  

At the time of this writing there are two clinics in Canada that provide DCA therapy for cancer. There may be more that were not found in an internet search.  

Port Moody Health in Vancouver

Medicor Cancer Centers in Toronto

Because DCA has been so thoroughly tested in humans over the past 30 years for the treatment of lactic acidosis, we know it is relatively non-toxic and safe when used in the prescribed dosages.  Medicor Cancer Centers have treated over 1,500 patients with DCA and has considerable experience.

According to Medicor, 44% of patients experience no side effects at all even at higher doses of up to 50 mg per kilogram of body weight.  A minimum dose is 20 mg per kilogram of body weight.  10% experience neuropathy in the extremities resulting in a feeling of numbness, tingling or feeling like pins are sticking in the skin.  2% experience loss of memory and hallucinations.  All symptoms are reversed by lowering or cycling the dosing. 

It takes approximately 3 weeks to build up a sufficient presence of the drug in the body to produce side effects (remember 44% do not experience side effects) and the speed of this is limited by the presence or absence of side effects.  No anti-cancer effect is seen at 10 mg/kg.  The effect is not seen until dosing reaches the 25 mg/kg rate and at 40 to 50 mg/kg the anti-cancer response is even greater.  Side effects can be minimized with supplements especially alpha lipoic acid and B vitamins (particularly B1).  If side effects occur, treatment can be cycled 2 or 3 weeks having treatment then a break of a week or so. 

A very good interview with two doctors from Medicor

 

DCA is available as a prescription drug in the USA as it is approved by the FDA for treating lactic acidosis.  If you live in the USA you may be able to find an alternative oriented doctor who will prescribe it for you.  Using it for treating a condition other than it’s intended use is called “going off label.”  At the time of this writing, we were not able to locate any clinics in the USA that were using DCA but that does not mean there are not any. 

Some people buy the DCA on line and treat themselves.  Line up a cooperative MD or Naturopath to help you monitor your progress.  It is important to trust the supplier.  Here is a web site that lists several suppliers.  The website claims to have tested the products of the suppliers and they have rated them.  The supplier they like the best is DC-Lab out of Lithuania and you can purchase their product on Amazon.  60 capsules at 500mg each are $99.  If you weigh 150 pounds, you will need to take 9 of these capsules a day (4500mg) to get a dose of 30mg per kilogram of body weight.  Even more if you dose at 40 or 50 mg.  That bottle of 60 capsules will last a little over 6 days and so plan on spending $500 a month for about 3 months.  Really that’s very cheap for a cancer treatment.

www.dcaguide.org

Also you might want to research 3BP (3-Bromopyruvate) and Salinomycin. 

 

Cancer Test

There is a blood test you can take for cancer that has been available for 30 years which is 99% accurate.  It won’t tell you what kind of cancer – only that cancer is present.  It will even indicate this before any cancer can be detected through standard procedures such as CAT scans.  It is more accurate, less dangerous and much cheaper than all other medical tests for cancer.  It is called the Anti-Malignin Antibody in Serum (AMAS) cancer test.  You don’t have to go to a doctor but you will need a doctor to prescribe it.  Medicare and other insurers pay for it.  The test costs $250.  The advantage is that you can test yourself for cancer as you proceed with your treatment and know when it is gone. The company is Oncolab in Boston.  Click on the following link to go to their site.

Oncolab


Chemotherapy Warning

Patients should be warned about the dangers of chemotherapy after research showed that cancer drugs are killing up to 50 per cent of patients in some hospitals. For the first time researchers looked at the numbers of cancer patients who died within 30 days of starting chemotherapy, which indicates that the medication is the cause of death, rather than the cancer.” There are serious effects from chemotherapy as seen in a 8/30/16 article by Sarah Knapton, science editor of The Telegraph.

Read Full Chemo Article

 

RETURN TO HOME PAGE

Copyright (C) 2018 Devi Press all rights reserved - CONTACT US - SITE MAP